Author: David J Sullivan

Downloads per author, site-wide

Preprints

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

• Downloaded 4,385 times
• Download rankings, all-time:
  • Site-wide: 3,691
  • In infectious diseases: 895
• Year to date:
  • Site-wide: 590
• Since beginning of last month:
  • Site-wide: 2,163

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy

• Downloaded 1,204 times
• Download rankings, all-time:
  • Site-wide: 24,764
  • In infectious diseases: 2,460
• Year to date:
  • Site-wide: 40,864
• Since beginning of last month:
  • Site-wide: 31,840

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers

• Downloaded 1,067 times
• Download rankings, all-time:
  • Site-wide: 29,726
  • In infectious diseases: 2,688
• Year to date:
  • Site-wide: 58,292
• Since beginning of last month:
  • Site-wide: 61,597

Analysis of anti-Omicron neutralizing antibody titers in plasma from pre-Omicron convalescents and vaccinees.

• Downloaded 939 times
• Download rankings, all-time:
  • Site-wide: 35,905
  • In infectious diseases: 2,986
• Year to date:
  • Site-wide: 5,794
• Since beginning of last month:
  • Site-wide: None

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers

• Downloaded 716 times
• Download rankings, all-time:
  • Site-wide: 53,064
  • In infectious diseases: 3,644
• Year to date:
  • Site-wide: 45,825
• Since beginning of last month:
  • Site-wide: 70,603

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2

• Downloaded 605 times
• Download rankings, all-time:
  • Site-wide: 66,417
  • In allergy and immunology: 158
• Year to date:
  • Site-wide: 36,679
• Since beginning of last month:
  • Site-wide: 61,665

High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern

• Downloaded 513 times
• Download rankings, all-time:
  • Site-wide: 81,257
  • In infectious diseases: None
• Year to date:
  • Site-wide: 3,407
• Since beginning of last month:
  • Site-wide: 4,122

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

• Downloaded 426 times
• Download rankings, all-time:
  • Site-wide: 99,327
  • In infectious diseases: 5,442
• Year to date:
  • Site-wide: 14,304
• Since beginning of last month:
  • Site-wide: 18,493